Asosiy kontentga oʻtish
AkademScholar
Jurnal

Clinical & Translational Oncology

ISSN:
1699-048X
3
h-indeks
13
Iqtiboslar
9
Asarlar

Ishonch signallari

1 dan 3 signal mavjud

Mustaqil ijobiy signallar — yagona “predator/qonuniy” hukmi emas, balki yaqinlashuvchi tasvir.

  • DOAJ
    Maʼlumot yoʻq
    doaj.org
  • OAK roʻyxati
    Maʼlumot yoʻq
    OAK
  • Yaroqli ISSN
    Mavjud
    ISSN

Bu axborot yorligʻi, rasmiy qaror emas. Signal yoʻqligi jazo emas — masalan, mintaqaviy jurnal DOAJ'da boʻlmasligi mumkin.

Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
03581005101520202520262025: Nashrlar 2, Iqtiboslar 12026: Nashrlar 7, Iqtiboslar 12

Iqtibos tarixi

05101520202520262025: Iqtiboslar 12026: Iqtiboslar 12

Nashr tarixi

035810202520262025: Nashrlar 22026: Nashrlar 7

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

01345202520262025: h-indeks 12026: h-indeks 3

Eng koʻp iqtibos qilingan asarlar

  1. Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology20264 iqtibos
  2. Circulating tumor DNA as a predictive biomarker for colorectal cancer postsurgical recurrence: a systematic review and meta-analysis20253 iqtibos
  3. The evolution of cellular-based immunotherapy in the treatment of gastric cancer: an overview of clinical trials20263 iqtibos
  4. Prognostic value of postoperative circulating tumor DNA for recurrence-free survival in resected non-small cell lung cancer: a systematic review and meta-analysis20252 iqtibos
  5. Circulating tumor DNA-based detection of molecular residual disease in isocitrate dehydrogenase-mutant cholangiocarcinoma for biomarker-guided therapy20261 iqtibos
  6. CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy20260 iqtibos
  7. Epigenetic insights and innovations for overcoming barriers in CAR-T cell therapy for cancer20260 iqtibos
  8. CAR-engineered neutrophils derived from induced pluripotent stem cells: a new frontier in cellular immunotherapy20260 iqtibos
  9. Trogocytosis in cancer immunity and cellular immunotherapy: mechanisms, therapeutic challenges, and translational opportunities20260 iqtibos